Advancing Group A Streptococcus Vaccine Discovery (R01 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-21-070 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support discovery and design of novel Group A Streptococcus (GAS) vaccine candidates and their advancement into preclinical evaluation for broad protection against GAS infections. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 15, 2021 Category: Research Source Type: funding